The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Barkalina N.V.

FGU "Nauchnyĭ tsentr akusherstva, ginekologii i perinatologii im. akad. V.I. Kulakova" Minzdravsotsrazvitiia Rossii, Moskva

Mishieva N.G.

FGU "Nauchnyĭ tsentr akusherstva, ginekologii i perinatologii im. akad. V.I. Kulakova" Minzdravsotsrazvitiia Rossii, Moskva

Abubakirov A.N.

FGU "Nauchnyĭ tsentr akusherstva, ginekologii i perinatologii im. akad. V.I. Kulakova" Minzdravsotsrazvitiia Rossii, Moskva

GNRH ANTAGONISTS IN ASSISTED REPRODUCTION (A REVIEW)

Authors:

Barkalina N.V., Mishieva N.G., Abubakirov A.N.

More about the authors

Journal: Russian Journal of Human Reproduction. 2012;(1): 65‑70

Read: 14091 times

Download PDF (RU)
Contact the author
Table of contents

GNRH ANTAGONISTS IN ASSISTED REPRODUCTION (A REVIEW)
GNRH ANTAGONISTS IN ASSISTED REPRODUCTION (A REVIEW)

To cite this article:

Barkalina NV, Mishieva NG, Abubakirov AN. GNRH ANTAGONISTS IN ASSISTED REPRODUCTION (A REVIEW). Russian Journal of Human Reproduction. 2012;(1):65‑70. (In Russ.)

Подписка 2026 Проблемы репродукции (Russian Journal of Human Reproduction)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Features of the course of indu­ced pregnancy during the transfer of a thawed embryo in women with poly­cystic ovary syndrome. Russian Journal of Human Reproduction. 2025;(1):54-62
Nutrient status of follicular fluid and blood serum in women with infe­rtility as a marker of embryo quality. Pilot study. Russian Journal of Human Reproduction. 2025;(2):17-27
Age-related pecu­liarities of blood para­meters in women and their impact on the outcome of in vitro fertilization programs. Russian Journal of Human Reproduction. 2025;(2):28-36
To the question of human oocy­tes dysmorphism and its influence on the para­meters of early embryogenesis. Russian Journal of Human Reproduction. 2025;(3):48-54
Comparative analysis of oocyte quality in patients with tubal-peritoneal gene­sis of infe­rtility in assi­sted reproductive technology programs. Russian Bulletin of Obstetrician-Gynecologist. 2024;(6):41-49
The expe­rience of using the nasal form of GnRH agonists in in vitro fertilization programs. Russian Bulletin of Obstetrician-Gynecologist. 2024;(6):79-84
The depe­ndence of the ploidic status of embryos on the state of the spindle of oocyte divi­sion, asse­ssed using pola­rization microscopy in IVF programs in women with ovarian endo­metriosis. Russian Bulletin of Obstetrician-Gynecologist. 2025;(1):44-49
The possibilities of predicting and redu­cing the risk of breast cancer in women against the background of the use of assi­sted reproductive technologies. Russian Bulletin of Obstetrician-Gynecologist. 2025;(1):59-64
Medi­cal and social characteristics of mate­rnal deaths after extracorporeal fertilization. Russian Bulletin of Obstetrician-Gynecologist. 2025;(2):5-14
Primary ovarian insu­fficiency: oppo­rtunities and prospects for the realization of reproductive function. Russian Bulletin of Obstetrician-Gynecologist. 2025;(2):42-47
Abstract:

The review focuses on the current use of GnRH antagonists in assisted reproduction. Existing premature LH surge prevention protocols with GnRH antagonists and their role in routine clinical practice are discussed. In addition, the review highlights modern strategies to improve the pregnancy rate in assisted reproduction.

Keywords:

GnRH antagonists
premature LH surge
assisted reproduction

Authors:

Barkalina N.V.

FGU "Nauchnyĭ tsentr akusherstva, ginekologii i perinatologii im. akad. V.I. Kulakova" Minzdravsotsrazvitiia Rossii, Moskva

Mishieva N.G.

FGU "Nauchnyĭ tsentr akusherstva, ginekologii i perinatologii im. akad. V.I. Kulakova" Minzdravsotsrazvitiia Rossii, Moskva

Abubakirov A.N.

FGU "Nauchnyĭ tsentr akusherstva, ginekologii i perinatologii im. akad. V.I. Kulakova" Minzdravsotsrazvitiia Rossii, Moskva

Close metadata

References:

  1. Klingmuller D., Schepke M., Enzweiler C., Bidlingmaier F. Hormonal responses to the new potent GnRH antagonist Cetrorelix. Acta Endocrinol (Copenh) 1993; 128: 15-18.
  2. Tarlatzis B.C., Fauser B.C., Kolibianakis E.M. et al. GnRH antagonists in ovarian stimulation for IVF. Hum Reprod Update 2006; 12: 4: 333-340.
  3. Reissmann T., Schally A.V., Bouchard P. et al. The LHRH antagonist cetrorelix: a review. Hum Reprod Update 2000; 6: 4: 322-331.
  4. Kolibianakis E.M., Tarlatzis B.C., Devroey P. GnRH antagonists in IVF. Reprod Biomed Online 2005; 10: 705-712.
  5. Al-Inany H.G., Abou-Setta A.M., Aboulghar M. Gonadotrophin-releasing hormone antagonists for assisted conception: a Cochrane review. Reprod Biomed Online 2007; 14: 5: 640-649.
  6. Johnston-MacAnanny E.B., DiLuigi A.J., Engmann L.L. et al. Selection of first in vitro fertilization cycle stimulation protocol for good prognosis patients: gonadotropin releasing hormone antagonist versus agonist protocols. J Reprod Med 2011; 56: 1-2: 12-16.
  7. Nazarenko T.A. Stimulyatsiya funktsii yaichnikov. M: MEDpress-inform 2008.
  8. Olivennes F., Belaisch-Allart J., Emperaire J.C. et al. Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin). Fertil Steril 2000; 73: 314-320.
  9. Wilcox J., Potter D., Moore M. et al. Prospective, randomized trial comparing cetrorelix acetate and ganirelix acetate in a programmed, flexible protocol for premature luteinizing hormone surge prevention in assisted reproductive technologies. Fertil Steril 2005; 84: 108-117.
  10. Al-Inany H.G., Aboulghar M., Mansour R., Serour G.I. Optimizing GnRH antagonist administration: metaanalysis of fixed vs flexible protocol. Reprod Biomed Online 2005; 10: 567.
  11. Kolibianakis E.M., Venetis C.A., Kalogeropoulou L. et al. Fixed versus flexible gonadotropin-releasing hormone antagonist administration in in vitro fertilization: a randomized controlled trial. Fertil Steril 2011; 95: 2: 558-562.
  12. Elnashar A.M. Progesterone rise on the day of HCG administration (premature luteinization) in IVF: an overdue update. J Ass Reprod Genet 2010; 27: 4: 149-155.
  13. Hofmann G.E., Bentzien F., Bergh P.A. et al. Premature luteinization in controlled ovarian hyperstimulation has no adverse effect on oocyte and embryo quality. Fertil Steril 1993; 60: 675-679.
  14. Silverberg K.M., Martin M., Olive D.L. et al. Elevated serum progesterone levels on the day of human chorionic gonadotropin administration in in vitro fertilization cycles do not adversely affect embryo quality. Fertil Steril 1994; 61: 508-513.
  15. Fanchin R., Ziegler D., Taieb J. et al. Premature elevation of plasma progesterone alters pregnancy rates of in vitro fertilization and embryo transfer. Fertil Steril 1993; 59: 1090-1094.
  16. Harada T., Yoshida S., Katagiri C. et al. Reduced implantation rate associated with a subtle rise in serum progesterone concentration during the follicular phase of cycles stimulated with a combination of a gonadotrophin-releasing hormone agonist and gonadotrophin. Hum Reprod 1995; 10: 1060-1064.
  17. Bosch E., Valencia I., Escudero E. et al. Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome. Fertil Steril 2003; 80: 1444-1449.
  18. Labarta E., Martínez-Conejero J.A., Alamá P. et al. Endometrial receptivity is affected in women with high circulating progesterone levels at the end of the follicular phase: a functional genomics analysis. Hum Reprod 2011.
  19. Li R., Qiao J., Wang L. et al. MicroRNA array and microarray evaluation of endometrial receptivity in patients with high serum progesterone levels on the day of hCG administration. Reprod Biol Endocrinol 2011; 6: 9: 29.
  20. Lainas T.G., Petsas G.K., Zorzovilis I.Z. et al. Initiation of GnRH antagonist on Day 1 of stimulation as compared to the long agonist protocol in PCOS patients. A randomized controlled trial: effect on hormonal levels and follicular development. Hum Reprod 2007; 22: 6: 1540-1546.
  21. Brzyski R.G., Muasher S.J., Droesch K. et al. Follicular atresia associated with concurrent initiation of gonadotropin-releasing hormone agonist and follicle-stimulating hormone for oocyte recruitment. Fertil Steril 1988; 50: 6: 917-921.
  22. Gelety T.J., Pearlstone A.C., Surrey E.S. Short-term endocrine response to gonadotropin-releasing hormone agonist initiated in the early follicular, midluteal, or late luteal phase in normally cycling women. Fertil Steril 1995; 64: 6: 1074-1080.
  23. San Roman G.A., Surrey E.S., Judd H.L. et al. A prospective randomized comparison of luteal phase versus concurrent follicular phase initiation of gonadotropin-releasing hormone agonist for in vitro fertilization. Fertil Steril 1992; 58: 4: 744-749.
  24. Griesinger G., Kolibianakis E.M., Venetis C. et al. Oral contraceptive pretreatment significantly reduces ongoing pregnancy likelihood in gonadotropin-releasing hormone antagonist cycles: an updated meta-analysis. Fertil Steril 2010; 94: 6: 2382-2384.
  25. Younis J.S., Soltsman S., Izhaki I. et al. Early and short follicular gonadotropin-releasing hormone antagonist supplementation improves the meiotic status and competence of retrieved oocytes in in vitro fertilization-embryo transfer cycles. Fertil Steril 2010; 94: 4: 1350-1355.
  26. Tang Y., Gong F., Lin G. et al. Early follicular progesterone concentrations and in vitro fertilization pregnancy outcomes. Fertil Steril 2007; 87: 4: 991-994.
  27. Blockeel C., Baumgarten M., De Vos M. et al. Administration of GnRH antagonists in case of elevated progesterone at initiation of the cycle: a prospective cohort study. Curr Pharm Biotechnol 2011; 12: 3: 423-428.
  28. Blockeel C., Riva A., De Vos M. et al. Administration of a gonadotropin-releasing hormone antagonist during the 3 days before the initiation of the in vitro fertilization/intracytoplasmic sperm injection treatment cycle: impact on ovarian stimulation. A pilot study. Fertil Steril 2011; 95: 5: 1714-1719.
  29. Al-Inany H.G., Youssef M.A., Aboulghar M. et al. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. Cochrane Database Syst Rev 2011; 11: 5: CD001750.
  30. Al-Inany H.G., Youssef M.A., Aboulghar M. et al. GnRH antagonists are safer than agonists: an update of a Cochrane review. Hum Reprod Update 2011; 17: 4: 435
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.